Edap Tms (NASDAQ:EDAP) Price Target Cut to $4.50 by Analysts at Piper Sandler

Edap Tms (NASDAQ:EDAP - Free Report) had its target price cut by Piper Sandler from $5.00 to $4.50 in a research note issued to investors on Friday morning,Benzinga reports. They currently have an overweight rating on the medical equipment provider's stock.

EDAP has been the subject of several other reports. HC Wainwright restated a "buy" rating and set a $19.00 price target on shares of Edap Tms in a report on Friday. StockNews.com began coverage on shares of Edap Tms in a research note on Friday. They set a "hold" rating for the company.

Edap Tms Price Performance

NASDAQ EDAP remained flat at $1.96 during trading hours on Friday. 209,847 shares of the company were exchanged, compared to its average volume of 87,847. Edap Tms has a one year low of $1.90 and a one year high of $8.50. The company has a current ratio of 2.18, a quick ratio of 1.46 and a debt-to-equity ratio of 0.08. The business's 50-day simple moving average is $2.42 and its 200-day simple moving average is $2.49. The company has a market cap of $72.72 million, a price-to-earnings ratio of -3.02 and a beta of 0.37.

Remove Ads

Edap Tms (NASDAQ:EDAP - Get Free Report) last released its earnings results on Thursday, March 27th. The medical equipment provider reported ($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.11) by $0.06. Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%. The firm had revenue of $22.69 million during the quarter, compared to analyst estimates of $20.83 million. Sell-side analysts forecast that Edap Tms will post -0.6 EPS for the current fiscal year.

Institutional Trading of Edap Tms

Institutional investors have recently made changes to their positions in the stock. Illumine Investment Management LLC bought a new position in shares of Edap Tms in the 4th quarter worth approximately $50,000. BNP Paribas Financial Markets raised its holdings in shares of Edap Tms by 23.7% during the 3rd quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider's stock worth $59,000 after acquiring an additional 4,400 shares in the last quarter. Jane Street Group LLC boosted its position in shares of Edap Tms by 174.7% during the 4th quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider's stock valued at $69,000 after acquiring an additional 73,361 shares during the last quarter. Millennium Management LLC grew its holdings in shares of Edap Tms by 218.5% in the fourth quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider's stock valued at $108,000 after purchasing an additional 33,558 shares in the last quarter. Finally, Orion Capital Management LLC increased its position in Edap Tms by 10.4% in the third quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider's stock worth $178,000 after purchasing an additional 6,600 shares during the last quarter. Hedge funds and other institutional investors own 62.74% of the company's stock.

Edap Tms Company Profile

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.